ANDA 81043, held by Alcon Pharms Ltd. Prednisolone Sodium Phosphate.
As of Nov 16, 2026, ANDA 81043 (Prednisolone Sodium Phosphate), held by Alcon Pharms Ltd, was first approved by FDA on Oct 24, 1991, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 24, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 0.11% PHOSPHATE ยท solution/drops;ophthalmic | Prednisolone Sodium Phosphate | Discontinued |
| Jun 11, 1999 | Supplement 9Manufacturing | Approved | None posted |
| Feb 19, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 6Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 5Manufacturing | Approved | None posted |
| May 31, 1996 | Supplement 4Manufacturing | Approved | None posted |
| Apr 16, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Jun 10, 1994 | Supplement 1Labeling | Approved | None posted |
| Dec 2, 1993 | Supplement 2Labeling | Approved | None posted |
| Oct 24, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters